SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

EPA:ALBFR • FR0010202606

112 EUR
-1.5 (-1.32%)
Last: Feb 24, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

ALBFR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 112 industry peers in the Software industry. ALBFR scores excellent on profitability, but there are some minor concerns on its financial health. ALBFR is growing strongly while it is still valued neutral. This is a good combination! These ratings could make ALBFR a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ALBFR had positive earnings in the past year.
  • In the past year ALBFR had a positive cash flow from operations.
  • In the past 5 years ALBFR has always been profitable.
  • ALBFR had a positive operating cash flow in each of the past 5 years.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • ALBFR has a Return On Assets of 9.46%. This is in the better half of the industry: ALBFR outperforms 69.64% of its industry peers.
  • ALBFR has a better Return On Equity (19.66%) than 73.21% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.28%, ALBFR is in the better half of the industry, outperforming 66.07% of the companies in the same industry.
  • ALBFR had an Average Return On Invested Capital over the past 3 years of 8.57%. This is below the industry average of 12.70%.
  • The last Return On Invested Capital (9.28%) for ALBFR is above the 3 year average (8.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROIC 9.28%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • ALBFR has a Profit Margin of 14.17%. This is in the better half of the industry: ALBFR outperforms 64.29% of its industry peers.
  • In the last couple of years the Profit Margin of ALBFR has grown nicely.
  • ALBFR's Operating Margin of 10.85% is in line compared to the rest of the industry. ALBFR outperforms 59.82% of its industry peers.
  • ALBFR's Operating Margin has improved in the last couple of years.
  • ALBFR has a Gross Margin (75.88%) which is in line with its industry peers.
  • ALBFR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALBFR is creating some value.
  • The number of shares outstanding for ALBFR has been increased compared to 1 year ago.
  • ALBFR has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ALBFR has been reduced compared to a year ago.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALBFR has an Altman-Z score of 4.00. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ALBFR (4.00) is better than 68.75% of its industry peers.
  • ALBFR has a debt to FCF ratio of 1.10. This is a very positive value and a sign of high solvency as it would only need 1.10 years to pay back of all of its debts.
  • The Debt to FCF ratio of ALBFR (1.10) is better than 70.54% of its industry peers.
  • ALBFR has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • ALBFR's Debt to Equity ratio of 0.16 is in line compared to the rest of the industry. ALBFR outperforms 58.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Altman-Z 4
ROIC/WACC1.12
WACC8.26%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALBFR has a Current Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBFR's Current ratio of 1.47 is in line compared to the rest of the industry. ALBFR outperforms 54.46% of its industry peers.
  • ALBFR has a Quick Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • ALBFR's Quick ratio of 1.47 is in line compared to the rest of the industry. ALBFR outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.87%, which is quite good.
  • ALBFR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.85% yearly.
  • The Revenue has grown by 24.74% in the past year. This is a very strong growth!
  • Measured over the past years, ALBFR shows a quite strong growth in Revenue. The Revenue has been growing by 16.43% on average per year.
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.42% on average over the next years. This is quite good.
  • ALBFR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.55% yearly.
EPS Next Y12.28%
EPS Next 2Y9.96%
EPS Next 3Y14.42%
EPS Next 5YN/A
Revenue Next Year12.77%
Revenue Next 2Y16.99%
Revenue Next 3Y15.55%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.18, ALBFR is valued on the expensive side.
  • Based on the Price/Earnings ratio, ALBFR is valued a bit cheaper than the industry average as 74.11% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of ALBFR to the average of the S&P500 Index (26.98), we can say ALBFR is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 17.26, which indicates a rather expensive current valuation of ALBFR.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR indicates a somewhat cheap valuation: ALBFR is cheaper than 71.43% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALBFR to the average of the S&P500 Index (28.01), we can say ALBFR is valued slightly cheaper.
Industry RankSector Rank
PE 20.18
Fwd PE 17.26
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • ALBFR's Enterprise Value to EBITDA ratio is in line with the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ALBFR.
Industry RankSector Rank
P/FCF 27.29
EV/EBITDA 19.19
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ALBFR may justify a higher PE ratio.
  • ALBFR's earnings are expected to grow with 14.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.64
PEG (5Y)0.72
EPS Next 2Y9.96%
EPS Next 3Y14.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALBFR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SIDETRADE

EPA:ALBFR (2/24/2026, 7:00:00 PM)

112

-1.5 (-1.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-14
Earnings (Next)03-31
Inst Owners18.82%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap168.00M
Revenue(TTM)59.46M
Net Income(TTM)8.43M
Analysts84
Price Target295.8 (164.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.75%
PT rev (3m)1.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.18
Fwd PE 17.26
P/S 2.83
P/FCF 27.29
P/OCF 23.74
P/B 3.92
P/tB 14.08
EV/EBITDA 19.19
EPS(TTM)5.55
EY4.96%
EPS(NY)6.49
Fwd EY5.79%
FCF(TTM)4.1
FCFY3.66%
OCF(TTM)4.72
OCFY4.21%
SpS39.64
BVpS28.58
TBVpS7.96
PEG (NY)1.64
PEG (5Y)0.72
Graham Number59.74
Profitability
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROCE 12.63%
ROIC 9.28%
ROICexc 19.81%
ROICexgc N/A
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
FCFM 10.35%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Debt/EBITDA 0.88
Cap/Depr 74.39%
Cap/Sales 1.55%
Interest Coverage 250
Cash Conversion 91.99%
Profit Quality 73.03%
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 4
F-Score6
WACC8.26%
ROIC/WACC1.12
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
EPS Next Y12.28%
EPS Next 2Y9.96%
EPS Next 3Y14.42%
EPS Next 5YN/A
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%
Revenue Next Year12.77%
Revenue Next 2Y16.99%
Revenue Next 3Y15.55%
Revenue Next 5YN/A
EBIT growth 1Y16.13%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year10.63%
EBIT Next 3Y13.67%
EBIT Next 5YN/A
FCF growth 1Y158.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y100%
OCF growth 3Y9.02%
OCF growth 5Y29.8%

SIDETRADE / ALBFR.PA FAQ

What is the ChartMill fundamental rating of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALBFR.PA.


What is the valuation status of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to SIDETRADE (ALBFR.PA). This can be considered as Fairly Valued.


How profitable is SIDETRADE (ALBFR.PA) stock?

SIDETRADE (ALBFR.PA) has a profitability rating of 7 / 10.


What is the valuation of SIDETRADE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SIDETRADE (ALBFR.PA) is 20.18 and the Price/Book (PB) ratio is 3.92.


What is the expected EPS growth for SIDETRADE (ALBFR.PA) stock?

The Earnings per Share (EPS) of SIDETRADE (ALBFR.PA) is expected to grow by 12.28% in the next year.